RT Journal Article
SR Electronic
T1 COVID-19 Vaccine Hesitancy among the Adult Population in Bangladesh: A Nationally Representative Cross-sectional Survey
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.23.21255844
DO 10.1101/2021.04.23.21255844
A1 Hossain, Mohammad Bellal
A1 Alam, Md. Zakiul
A1 Islam, Md. Syful
A1 Sultan, Shafayat
A1 Faysal, Md. Mahir
A1 Rima, Sharmin
A1 Hossain, Md. Anwer
A1 Mamun, Abdullah Al
YR 2021
UL http://medrxiv.org/content/early/2021/04/25/2021.04.23.21255844.abstract
AB Introduction The study related to the COVID-19 vaccine hesitancy is scanty in the context of Bangladesh, despite the growing necessity of understanding the mass people’s vaccination-related behavior. Thus, the present study was conducted to assess the prevalence of the COVID-19 vaccine hesitancy and its associated factors in Bangladesh to fill the knowledge gap.Methodology This study adopted a cross-sectional study design to collect data from 1497 respondents using online (Google forms) and face-to-face interviews. We employed descriptive statistics and multiple hierarchical linear regression analysis.Findings The prevalence of vaccine hesitancy was 41.1%. Men had less hesitancy (β = -0.046, p = 0.030) than women. The Muslims (β = 0.057, p = 0.009) and the respondents living in the city corporation areas (β = 0.132, p <0.001) had more hesitancy. There was significant variation in vaccine hesitancy by administrative divisions (geographic regions). The vaccine hesitancy tended to decrease with increasing knowledge about the vaccine (β = -0.072, p=0.001) and the vaccination process (β= -0.058, p = 0.018). On the other hand, hesitancy increased with the increased negative attitudes towards vaccine (β = 0.291, p <0.001) and conspiracy beliefs towards the COVID-19 vaccine (β = 0.105, p=0.004). The perceived severity of the COVID-19 (β = -0.079, p=0.002) and perceived benefits of COVID-19 vaccination (β = -0.180, p=0.001) were negatively associated with hesitancy, while perceived barriers (β = 0.180, p <0.001) were positively associated. The participants were more hesitant to accept the vaccine from a specific manufacturer.Conclusion This study emphasizes that negative attitudes and conspiracies towards the COVID-19 vaccine should be reduced through effective communications and contracting with additional vaccine manufacturers should be prioritized. The barriers like online registration for receiving the COVID-19 vaccination need to be removed, and initiatives like text message service using the mobile phone operator can be introduced.HighlightsAbout 41% of the respondents had had hesitancy to accept the COVID-19 vaccine.The hesitancy increased with negative attitudes about vaccines and conspiracy beliefs.Perceived barriers to receive the vaccine were increasing vaccine hesitancy.Perceived severity of the COVID-19 decreased the vaccine hesitancy.Perceived benefits of receiving the COVID-19 vaccine decreased the vaccine hesitancy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received no funding or whatsoever from any organization or donor agency.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We received ethical approval from the National Research Ethics Committee of the Bangladesh Medical Research Council (BMRC).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available from the Corresponding Author.